Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 1-2, 2006, Pages 66-70

  Wang, Li Hong ^a   Jin, Zheng Ming ^a   Chen, Jun Zhu ^a   Zhu, Jian Hua ^a   Zheng, Lian Rong ^a   Tao, Qian Ming ^a   Zhang, Fu Rong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Heparin; Platelet aggregability; Radiofrequency catheter ablation; Thromboxane B2

Indexed keywords

HEPARIN; THROMBOXANE B2;

ADULT; ARTICLE; BLEEDING; BLOOD SAMPLING; CATHETER ABLATION; CONTROLLED STUDY; DRUG EFFECT; DRUG ERUPTION; FEMALE; HEART ELECTROPHYSIOLOGY; HUMAN; INHIBITION KINETICS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION; TACHYCARDIA, SUPRAVENTRICULAR; THROMBOEMBOLISM; THROMBOXANE B2; TREATMENT OUTCOME;

EID: 33645064008     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04325.x     Document Type: Article

References (23)

1. Metzger JT Cheriex EC Smeets JL et al. Safety of radiofrequency catheter ablation of accessory atrioventricular pathways AmHeart J 1994 127 1533 8
2. Trouton TG O'Nunain SS Kim YH Sosa-Suarez GE Garan H Ruskin JN Curative transcatheter radiofrequency current ablation for atrioventricular nodal reentry tachycardia ArchInternMed 1994 154 1226 31
3. Schluter M Kuck KH Radiofrequency current therapy of supraventricular tachycardia: Accessory atrioventricular pathways PACE 1993 16 643 8
4. Zhou L Keane D Reed G Ruskin J Thromboembolic complications of cardiac radiofrequency catheter ablation: A review of the reported incidence, pathogenesis and current research directions JCardiovascElectrophysiol 1999 10 611 20
5. Hindricks G The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology EurHeart J 1993 14 1644 53
6. Thakur RK Klein GJ Yee R Embolic complications in Multicentre European Radiofrequency Survey (MERFS) EurHeart J 1994 15 1290 1
7. Calkins H Yong P Miller JM et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: Final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigations Group Circulation 1999 99 262 70
8. Anfinsen OG Gjesdal K Aass H Brosstad F Orning OM Amlie JP When should heparin preferably be administered during radiofrequency catheter ablation? Pacing ClinElectrophysiol 2001 24 5 12
9. Manolis AS Maounis T Vassilikos V et al. Pretreatment with antithrombotic agents during radiofrequency catheter ablation: A randomized comparison of aspirin versus ticlopidine JCardiovascElectrophysiol 1998 9 1144 51
10. Manolis AS Vassilikos V Maounis TN et al. Pretreatment with aspirin and tidopidine confers lower thrombogenic potential of radiofrequency catheter ablation AmJCardiol 1997 79 494 7
11. Anfinsen OG Gjesdal K Brosstad F et al. The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients JCardiovascElectrophysiol 1999 10 503 12
12. Upchurch GR Valeri CR Khuri SF et al. Effect of heparin on fibrinolytic activity and platelet function in vivo AmJPhysiol 1996 271 H528 34
13. Fareed J Walenga JM Hoppensteadt DA Messmore HL Studies on the profibrinolytic actions of heparin and its fractions SeminThrombHemost 1985 11 199 207
14. Vairel EG Bouty-Boye H Toulemonde F Doutremepuich C Marsh NA Gaffney PJ Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis ThrombRes 1983 30 219 24
15. Wang TL Lin JL Hwang JJ et al. The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: The role of antiplatelet therapy Pacing ClinElectrophysiol 1995 18 1980 9
16. Begent NA Born GV Quantitative investigation of intravascular platelet aggregation JPhysiol 1970 210 P40 1 (Abstract)
17. Wang LH Chen JZ Zheng LR Tao QM Effect of pretreatment with aspirin and ticlopidine on the activity of platelet during radiofrequency catheter ablation ChinJHematol 2002 23 492 3
18. Eidt JF Allison P Noble S et al. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury JClinInvest 1989 84 18 27
19. Kelly AB Marzec UM Krupski W et al. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons Blood 1991 77 1006 12
20. Kowalski E Kopac M Wegrzyowitz U Influence of fiberinogen degration products (FDP) on platelet aggregation, adhesion and viscous metamorphosis ThrombDiathHaemorrh 1963 10 406 13
21. Ni GS (ed.) Clinical Application of Drugs 1st edn Bayi Publishers
22. Perrault C Ajzenberg N Legendre P et al. Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib Blood 1999 94 4186 94
23. Charng MJ Lin YJ Chiu TY Cheng CM Ding PY Comparison of hemostatic activation created by right- and left-heart radiofrequency catheter ablation ClinCardiol 2004 27 91 6